FDG-PET/CT in Lung Cancer: An Update

被引：0
|
作者：
Baum, Richard P. [1 ]
Swietaszczyk, Cyprian [1 ]
Prasad, Vikas [1 ]
机构：
[1] Zent Klin Bad Berka, Dept Nucl Med, Ctr PET, DE-99437 Bad Berka, Germany
来源：
CONTROVERSIES IN TREATMENT OF LUNG CANCER | 2010年 / 42卷
关键词：
POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; SOLITARY PULMONARY NODULES; TREE SENSITIVITY-ANALYSIS; MEDIASTINAL LYMPH-NODES; GROSS TUMOR VOLUME; FINE-NEEDLE-ASPIRATION; GLUCOSE METABOLIC-RATE; DIAGNOSTIC WORK-UP; COST-EFFECTIVENESS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prognosis of lung cancer patients mostly depends on the stage at which the disease is diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging, but often the morphological information is insufficient when compared to the metabolic or molecular information obtained by positron emission tomography (PET). [18]F-fluorine deoxyglucose (FDG) is based upon the increased demand of ATP leading to increased consumption of glucose in the tumor tissues. FDG-PET/CT has been proven to be of immense value in the initial diagnosis, evaluation of therapy reponse, detection of recurrent tumor, radiation therapy planning and in the multidisciplinary management of patients with non-small cell lung cancer as well as in patients with small cell lung cancer. The aim of this article is to present a concise summary of the present status of FOG-PET/CT. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码：15 / 45
页数：31
相关论文
共 50 条
  • [41] The Diagnostic Value of FDG-PET/CT for Urachal Cancer
    Stokkel, Laura E.
    Stokkel, Marcel P. M.
    Donswijk, Maarten L.
    Lahaye, Max J.
    Bekers, Elise M.
    van Rhijn, Bas W. G.
    Mertens, Laura S.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : 373 - 380
  • [42] FDG-PET/CT for initial staging of colorectal cancer
    Petersen, Rasmus
    Hess, Soren
    Alavi, Abass
    Hoilund-Carlsen, Poul
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [43] Detection of unexpected prostate cancer with FDG-PET/CT
    Ishimori, Takayoshi
    Ishibashi, Mana
    Yamada, Tsuyoshi
    Watanabe, Yuji
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [44] FDG-PET/CT as a molecular biomarker in ovarian cancer
    Nowosinska, Ewa
    Avril, Stefanie
    Murray, Iain
    Szyszko, Teresa
    Avril, Norbert
    [J]. CANCER BIOMARKERS, 2010, 8 (4-5) : 167 - 175
  • [45] The Study of FDG-PET/CT Sensitivity for Gastric Cancer
    Kawaguchi, Kiyoshi
    Urayama, Masahiro
    Toda, Makoto
    Isobe, Hideki
    Moriya, Toshiyuki
    Ohta, Keiji
    Fuse, Akira
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S1052 - S1052
  • [46] FDG-PET/CT differ lung carcinoids from hamartomas
    Grundberg, Oscar
    Jacobsson, Hans
    Kolbeck, Karl Gustav
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S735 - S735
  • [47] Imaging of oesophageal cancer with FDG-PET/CT and MRI
    van Rossum, P. S. N.
    van Lier, A. L. H. M. W.
    Lips, I. M.
    Meijer, G. J.
    Reerink, O.
    van Vulpen, M.
    Lam, M. G. E. H.
    van Hillegersberg, R.
    Ruurda, J. P.
    [J]. CLINICAL RADIOLOGY, 2015, 70 (01) : 81 - 95
  • [48] FDG-PET/CT finding of benign metastasizing leiomyoma of the lung
    Nakajo, Masatoyo
    Nakayama, Hirofumi
    Sato, Masayuki
    Fukukura, Yoshihiko
    Nakajo, Masayuki
    Kajiya, Yoriko
    Yanagi, Masakazu
    Tabata, Kazuhiro
    Higashi, Michiyo
    [J]. ACTA RADIOLOGICA OPEN, 2012, 1 (03):
  • [49] FDG-PET/CT in predicting aggressiveness of rectal cancer
    Ahmed, Iman Sherif
    El Gaafary, Saher Mohamed
    Elia, Remon Zaher
    Hussein, Rasha S.
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):
  • [50] USE OF FDG-PET/CT IN STAGING OF BLADDER CANCER
    Sur, Hariom
    Dowson, Christopher
    Lewis, Thomas
    Rallon, Priya
    Sriram, Rajagopalan
    Macdonald, Donald
    Jefferson, Kieran
    [J]. JOURNAL OF ENDOUROLOGY, 2012, 26 : A91 - A92
12345